Alterations in the intestinal microbiome and metabolic profile of patients with cirrhosis supplemented with lactulose, Clostridium butyricum, and Bifidobacterium longum infantis: a randomized placebo-controlled trial

Alterations in the intestinal microbiome and metabolic profile of patients with cirrhosis supplemented with lactulose, Clostridium butyricum, and Bifidobacterium longum infantis: a randomized placebo-controlled trial

BackgroundLiver cirrhosis is commonly accompanied by intestinal dysbiosis and metabolic defects. Many clinical trials have shown microbiota-targeting strategies represent promising interventions for managing cirrhosis and its complications. However, the influences of the intestinal metagenomes and m...

Full description

Bibliographic Details
Main Authors: Haifeng Lu, Xiaofei Zhu, Lingyun Wu, Xiaobin Lou, Xiaxia Pan, Bowen Liu, Hua Zhang, Lingxiao Zhu, Lanjuan Li, Zhongwen Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Microbiology
Subjects:
cirrhosis
synbiotics
shotgun metagenomics
untargeted metabolomics
Bifidobacterium longum
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2023.1169811/full

Internet

https://www.frontiersin.org/articles/10.3389/fmicb.2023.1169811/full

Similar Items